Search
Search
Eyewire News: The Podcast
08.26.26
Eyepoint Pharmaceuticals releases key phase 3 data for its wet AMD drug Duravyu; Zeiss receives FDA clearance for a cloud- and browser-based data management solution; and the FDA expands Sight Sciences’ indications for the TearCare System for the treatment of MGD. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
07.22.26
PRIMA Retinal Implant Launched in EUShow More
